Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

QT Interval in Patients With COVID-19

QT Interval in Patients With COVID-19 Letters 6. Glynn P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in Corresponding Author: Matteo Bianco, MD, Cardiology Division, San Luigi cardiovascular mortality related to heart failure in the United States. JAmColl Gonzaga University Hospital, Regione Gonzole 10, Orbassano, Turin 10043, Italy Cardiol. 2019;73(18):2354-2355. doi:10.1016/j.jacc.2019.02.042 (matteo.bianco87@gmail.com). Published Online: October 21, 2020. doi:10.1001/jamacardio.2020.4952 Conflict of Interest Disclosures: None reported. COMMENT & RESPONSE 1. Bessière F, Roccia H, Delinière A, et al. Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an To the Editor We read with great interest the publications by intensive care unit. JAMA Cardiol. 2020;5(9):1067-1069. doi:10.1001/ 1 2 jamacardio.2020.1787 Bessière et al and Mercuro et al regarding the QT prolongation 2. Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT interval prolongation in patients with coronavirus disease 2019 (COVID-19)–related associated with use of hydroxychloroquine with or without concomitant pneumonia treated with hydroxychloroquine. Both the studies azithromycin among hospitalized patients testing positive for coronavirus raised safety concern about hydroxychloroquine usage second- disease 2019 (COVID-19). JAMA Cardiol. 2020;5(9):1036-1041. doi:10.1001/ ary to a higher than expected QT prolongation connected http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

QT Interval in Patients With COVID-19

Loading next page...
 
/lp/american-medical-association/qt-interval-in-patients-with-covid-19-EeQCYOAJ0i
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2020.4952
Publisher site
See Article on Publisher Site

Abstract

Letters 6. Glynn P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in Corresponding Author: Matteo Bianco, MD, Cardiology Division, San Luigi cardiovascular mortality related to heart failure in the United States. JAmColl Gonzaga University Hospital, Regione Gonzole 10, Orbassano, Turin 10043, Italy Cardiol. 2019;73(18):2354-2355. doi:10.1016/j.jacc.2019.02.042 (matteo.bianco87@gmail.com). Published Online: October 21, 2020. doi:10.1001/jamacardio.2020.4952 Conflict of Interest Disclosures: None reported. COMMENT & RESPONSE 1. Bessière F, Roccia H, Delinière A, et al. Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an To the Editor We read with great interest the publications by intensive care unit. JAMA Cardiol. 2020;5(9):1067-1069. doi:10.1001/ 1 2 jamacardio.2020.1787 Bessière et al and Mercuro et al regarding the QT prolongation 2. Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT interval prolongation in patients with coronavirus disease 2019 (COVID-19)–related associated with use of hydroxychloroquine with or without concomitant pneumonia treated with hydroxychloroquine. Both the studies azithromycin among hospitalized patients testing positive for coronavirus raised safety concern about hydroxychloroquine usage second- disease 2019 (COVID-19). JAMA Cardiol. 2020;5(9):1036-1041. doi:10.1001/ ary to a higher than expected QT prolongation connected

Journal

JAMA CardiologyAmerican Medical Association

Published: Mar 21, 2021

References